Industry Trends: Cycle Time to Resolve Risk Signals

Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study team intervention to address any confirmed issues and thereby drive optimal quality outcomes.

Guide

A Comprehensive Guide to Adaptive Site Monitoring

Blog

ICH E6(R3), Demystified Part 2 | Defining Critical-to-Quality

Ethical and Actionable Trial Outcomes ICH E6(R3) is more than just an update to Good Clinical...

Press Release

CluePoints Appoints New Chief People Officer to Support Next Phase of Global Growth

King of Prussia, PA – January 12, 2026 – CluePoints, provider of leading statistical and AI-driven...

Blog

ICH E6(R3), Demystified: Turning Guidance into Oversight | Part 1

The New Era of Good Clinical Practice: A Practical Guide for Sponsors and CROs The updated...